SIDE EFFECT MANAGEMENT

Feature

Can Modifying Microbial Diversity Change Outcomes Following Allogeneic HSCT?

By

Some studies have found a link between intestinal microbiota composition and development of acute graft-versus-host disease.

Latest

Can Modifying Microbial Diversity Change Outcomes Following Allogeneic HSCT?

By

Some studies have found a link between intestinal microbiota composition and development of acute graft-versus-host disease.

Risk Factors for Chemotherapy-Induced Nausea in Pediatric Patients

By

Nonwhite race, poor acute phase nausea control, and treatment with cisplatin were all associated with higher self-reported nausea severity scores.

Opioid Therapy for Cancer Pain May Be Associated With High Risk for Aberrant Opioid Use

Patients taking opioids for cancer-related pain at outpatient supportive pain consultations may be at higher risk for aberrant opioid and drug use behavior.

Managing Immune-Related Adverse Events

By Andrea S. Blevins Primeau, PhD, MBA

An overview of the potential immune-related adverse events that can arise from treatment with checkpoint inhibitors.

Cancer-Related Fatigue May Predict Reduced Survival in Newly Diagnosed Multiple Myeloma

By James Nam, PharmD

Researchers investigated cancer-related fatigue in 16 patients with multiple myeloma who were treated with bortezomib, lenalidomide, or thalidomide.

SIGN UP FOR FREE E-NEWSLETTERS